156.75
price up icon1.43%   2.21
 
loading
Schlusskurs vom Vortag:
$154.54
Offen:
$158
24-Stunden-Volumen:
1.65M
Relative Volume:
1.81
Marktkapitalisierung:
$8.82B
Einnahmen:
$633.51M
Nettoeinkommen (Verlust:
$-8.10M
KGV:
-505.65
EPS:
-0.31
Netto-Cashflow:
$131.26M
1W Leistung:
+5.63%
1M Leistung:
+28.17%
6M Leistung:
+19.07%
1J Leistung:
+5.05%
1-Tages-Spanne:
Value
$156.50
$165.17
1-Wochen-Bereich:
Value
$147.16
$165.17
52-Wochen-Spanne:
Value
$102.97
$182.52

Repligen Corp Stock (RGEN) Company Profile

Name
Firmenname
Repligen Corp
Name
Telefon
(781) 449-9560
Name
Adresse
41 SEYON STREET, WALTHAM, MA
Name
Mitarbeiter
1,778
Name
Twitter
@repligen
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
RGEN's Discussions on Twitter

Vergleichen Sie RGEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
RGEN
Repligen Corp
156.75 8.69B 633.51M -8.10M 131.26M -0.31
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
462.74 164.35B 9.15B 2.63B 1.99B 7.1661
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
189.03 54.75B 21.39B 1.61B 2.55B 5.5609
Medical Instruments & Supplies icon
RMD
Resmed Inc
268.22 39.61B 5.15B 1.40B 1.65B 9.5082
Medical Instruments & Supplies icon
ALC
Alcon Inc
75.76 37.31B 10.03B 1.07B 1.39B 2.1549
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
279.39 19.77B 2.96B 487.70M 344.00M 6.6758

Repligen Corp Stock (RGEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-01 Eingeleitet HSBC Securities Buy
2025-09-22 Hochstufung Evercore ISI In-line → Outperform
2025-07-22 Fortgesetzt Stephens Overweight
2025-06-24 Eingeleitet Barclays Overweight
2025-04-29 Hochstufung Wolfe Research Peer Perform → Outperform
2025-03-18 Eingeleitet Evercore ISI In-line
2025-02-10 Eingeleitet TD Cowen Buy
2024-12-17 Eingeleitet Canaccord Genuity Hold
2024-11-14 Eingeleitet Wolfe Research Peer Perform
2024-08-28 Eingeleitet Wells Fargo Overweight
2024-06-26 Hochstufung Deutsche Bank Hold → Buy
2024-06-18 Eingeleitet Guggenheim Neutral
2023-12-04 Herabstufung The Benchmark Company Buy → Hold
2023-07-20 Eingeleitet Wells Fargo Overweight
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-03-28 Eingeleitet The Benchmark Company Buy
2022-12-14 Eingeleitet Deutsche Bank Hold
2022-12-07 Eingeleitet RBC Capital Mkts Sector Perform
2022-07-20 Eingeleitet UBS Buy
2021-10-14 Eingeleitet Exane BNP Paribas Outperform
2020-11-10 Eingeleitet KeyBanc Capital Markets Overweight
2020-08-24 Bestätigt H.C. Wainwright Buy
2020-06-30 Bestätigt H.C. Wainwright Buy
2020-05-07 Bestätigt H.C. Wainwright Buy
2020-03-23 Bestätigt H.C. Wainwright Buy
2019-11-15 Eingeleitet Stifel Buy
2019-11-01 Hochstufung First Analysis Sec Outperform → Strong Buy
2019-10-15 Eingeleitet SVB Leerink Outperform
2019-08-28 Bestätigt First Analysis Sec Outperform
2019-08-23 Fortgesetzt Stephens Overweight
2019-07-22 Hochstufung H.C. Wainwright Neutral → Buy
2018-12-17 Hochstufung CL King Neutral → Buy
2018-11-12 Herabstufung CL King Buy → Neutral
2018-09-26 Eingeleitet H.C. Wainwright Neutral
2017-12-08 Eingeleitet Citigroup Buy
2017-12-05 Eingeleitet JP Morgan Overweight
2017-11-13 Eingeleitet CL King Buy
2017-10-02 Hochstufung First Analysis Sec Equal-Weight → Overweight
2017-07-21 Eingeleitet William Blair Outperform
2017-02-13 Hochstufung Piper Jaffray Neutral → Overweight
Alle ansehen

Repligen Corp Aktie (RGEN) Neueste Nachrichten

pulisher
01:04 AM

What makes Repligen Corporation stock attractive to growth fundsQuarterly Performance Summary & Expert-Curated Trade Recommendations - newser.com

01:04 AM
pulisher
Oct 21, 2025

Earnings Preview: Repligen (RGEN) Q3 Earnings Expected to Decline - Yahoo Finance

Oct 21, 2025
pulisher
Oct 21, 2025

Is it time to cut losses on Repligen CorporationRate Cut & High Conviction Buy Zone Alerts - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Using data tools to time your Repligen Corporation exit2025 Volatility Report & Free Technical Confirmation Trade Alerts - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Repligen Corporation (RGEN) Stock forecasts - Yahoo

Oct 20, 2025
pulisher
Oct 20, 2025

Will Repligen Corporation (RGN) stock hit Wall Street targetsPortfolio Risk Report & Daily Chart Pattern Signal Reports - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Repligen Corporation (RGEN) Stock Forecasts - Yahoo

Oct 20, 2025
pulisher
Oct 20, 2025

Published on: 2025-10-20 12:44:23 - newser.com

Oct 20, 2025
pulisher
Oct 18, 2025

Is Repligen Corporation stock affected by interest rate hikesIPO Watch & Smart Swing Trading Techniques - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Nasdaq Moves: Why Repligen Corporation stock attracts global investorsPortfolio Profit Report & AI Driven Stock Movement Reports - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

US Bancorp DE Sells 1,463 Shares of Repligen Corporation $RGEN - Defense World

Oct 18, 2025
pulisher
Oct 18, 2025

What analyst consensus says on Repligen Corporation stockJuly 2025 Highlights & Reliable Volume Spike Alerts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

Technical signs of recovery in Repligen CorporationWall Street Watch & Free Community Supported Trade Ideas - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

Manufacturing Stocks To Follow TodayOctober 17th - MarketBeat

Oct 17, 2025
pulisher
Oct 17, 2025

Why Repligen Corporation stock remains a top recommendationJuly 2025 Volume & Short-Term Trading Alerts - Trung tâm Dự báo KTTV quốc gia

Oct 17, 2025
pulisher
Oct 17, 2025

Does Repligen Corporation stock trade at a discount to peersDip Buying & Free Fast Gain Swing Trade Alerts - newser.com

Oct 17, 2025
pulisher
Oct 16, 2025

Q1 Earnings Estimate for Repligen Issued By Leerink Partnrs - Defense World

Oct 16, 2025
pulisher
Oct 15, 2025

Tools to monitor Repligen Corporation recovery probabilityJuly 2025 Recap & Expert Approved Momentum Ideas - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Repligen to Report Third Quarter 2025 Financial Results - The Globe and Mail

Oct 15, 2025
pulisher
Oct 14, 2025

Repligen Corp. Experiences Evaluation Revision Amid Mixed Performance Indicators and Market Dynamics - Markets Mojo

Oct 14, 2025
pulisher
Oct 14, 2025

Earnings call transcript: Repligen Q2 2025 sees revenue growth, stock dips - Investing.com

Oct 14, 2025
pulisher
Oct 14, 2025

Repligen Stock Price Today | NASDAQ: RGEN Live - Investing.com

Oct 14, 2025
pulisher
Oct 13, 2025

Repligen price target raised to $160 from $150 at Barclays - MSN

Oct 13, 2025
pulisher
Oct 13, 2025

Historical volatility pattern of Repligen Corporation visualizedIPO Watch & Expert Curated Trade Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Repligen Corporation (RGEN) Stock Analysis: An Investor’s Guide to a 23.4% Potential Upside - DirectorsTalk Interviews

Oct 13, 2025
pulisher
Oct 11, 2025

Repligen (NASDAQ:RGEN) Rating Increased to Buy at Wall Street Zen - Defense World

Oct 11, 2025
pulisher
Oct 10, 2025

Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know - Barchart.com

Oct 10, 2025
pulisher
Oct 10, 2025

Hollow Fiber Filtration Market Is Booming Worldwide 2025-2032 | - openPR.com

Oct 10, 2025
pulisher
Oct 10, 2025

Repligen (RGEN) Receives a Hold from Guggenheim - The Globe and Mail

Oct 10, 2025
pulisher
Oct 09, 2025

Is Repligen (RGEN) The Best Healthcare Stock to Buy Now? - Insider Monkey

Oct 09, 2025
pulisher
Oct 09, 2025

Repligen Corporation’s volatility index tracking explainedWall Street Watch & Verified Trade Idea Suggestions - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Can technical indicators confirm Repligen Corporation’s reversal - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Repligen Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Oct 08, 2025
pulisher
Oct 08, 2025

Repligen’s SWOT analysis: bioprocessing leader faces growth challenges - Investing.com

Oct 08, 2025
pulisher
Oct 08, 2025

Evercore ISI Issues Positive Forecast for Repligen (NASDAQ:RGEN) Stock Price - Defense World

Oct 08, 2025
pulisher
Oct 07, 2025

RGEN: Evercore ISI Group Maintains "Outperform" Rating, Raises P - GuruFocus

Oct 07, 2025
pulisher
Oct 07, 2025

Evercore Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $175 - 富途牛牛

Oct 07, 2025
pulisher
Oct 06, 2025

Repligen (RGEN): Assessing Valuation Following HSBC’s Positive Coverage and Renewed Biotech Optimism - simplywall.st

Oct 06, 2025
pulisher
Oct 06, 2025

Short interest data insights for Repligen CorporationMarket Volume Report & Safe Entry Point Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

111 Capital Purchases New Holdings in Repligen Corporation $RGEN - MarketBeat

Oct 06, 2025
pulisher
Oct 05, 2025

What indicators show strength in Repligen Corporation2025 Historical Comparison & Weekly Setup with High ROI Potential - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Can New Analyst Attention on RGEN Reveal the True Strength of Repligen's Bioprocessing Edge? - simplywall.st

Oct 04, 2025
pulisher
Oct 04, 2025

Is Repligen’s Recent 18% Price Surge Justified After Broad Biotech Rally? - Yahoo Finance

Oct 04, 2025
pulisher
Oct 04, 2025

Why Investors Shouldn't Be Surprised By Repligen Corporation's (NASDAQ:RGEN) 28% Share Price Surge - simplywall.st

Oct 04, 2025
pulisher
Oct 03, 2025

Why Repligen Corporation stock attracts global investorsMarket Sentiment Report & Real-Time Volume Analysis - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Key metrics from Repligen Corporation’s quarterly dataWeekly Trade Report & Community Shared Stock Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Why Repligen Corporation stock is a must watch in 2025July 2025 Movers & Accurate Intraday Trading Signals - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 00:54:45 - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Applying big data sentiment scoring on Repligen Corporation2025 Risk Factors & Reliable Breakout Forecasts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

GAMMA Investing LLC Sells 132 Shares of Repligen Corporation $RGEN - Defense World

Oct 02, 2025

Finanzdaten der Repligen Corp-Aktie (RGEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$15.60
price up icon 2.77%
medical_instruments_supplies BAX
$22.75
price down icon 1.64%
$72.91
price up icon 0.05%
medical_instruments_supplies COO
$75.00
price up icon 0.01%
$73.98
price up icon 2.94%
medical_instruments_supplies WST
$279.39
price up icon 1.63%
Kapitalisierung:     |  Volumen (24h):